Limitations of the Program for Uninsured COVID-19 Patients Raise Concerns
The Trump administration's program to treat uninsured COVID-19 patients has limitations that are leaving some patients unprotected from large medical bills.
View the Latest: Vaccines
Filter
-
-
Racial Disparities in Flu Vaccination: Implications for COVID-19 Vaccination Efforts
Policy WatchWith planning beginning for an eventual COVID-19 vaccine, one important consideration is making sure that distribution processes and outreach and communication strategies reach people of color. Analysis of seasonal flu vaccination rates provides some insight into the potential barriers and issues to be addressed as part of COVID-19 vaccination efforts.
-
KFF Health Tracking Poll – September 2020: Top Issues in 2020 Election, The Role of Misinformation, and Views on A Potential Coronavirus Vaccine
ReportThe poll examines the public's views on the coronavirus pandemic and a COVID-19 vaccine, as well as trust and confidence in public figures and institutions. It also gauges what issues voters are prioritizing in the upcoming presidential election. and finds that Republican and independent voters prioritize the economy, while Democratic voters are more focused on the coronavirus outbreak.
-
Poll: Most Americans Worry Political Pressure Will Lead to Premature Approval of a COVID-19 Vaccine; Half Say They Would Not Get a Free Vaccine Approved Before Election Day
News ReleaseRepublican and Independent Voters See the Economy as Their Top Issue; Coronavirus and Race Relations Top Democrats’ List Most Americans (62%) worry that the political pressure from the Trump administration will lead the Food and Drug Administration to rush to approve a coronavirus vaccine without making sure that it is safe and effective, the latest…
-
Pharmacies, Not the Military, Will Handle COVID-19 Vaccinations
From Drew AltmanPresident Trump has conjured up the image of a top general and the military delivering the coronavirus vaccine drawing on their vast logistical experience. In his latest Axios column, Drew Altman explains why vaccine realities will dictate that it’s much more likely to be at your local Walgreens or CVS pharmacy.
-
The Coronavirus Aid, Relief, and Economic Security Act: Summary of Key Health Provisions
Issue BriefThis summary of the Coronavirus Aid, Relief, and Economic Security (CARES) Act highlights and summarizes health-related provisions focused on the COVID-19 outbreak in the United States and support for the global response.
-
The Families First Coronavirus Response Act: Summary of Key Provisions
Issue BriefA summary of key provisions of the Families First Coronavirus Response Act that addresses the domestic coronavirus outbreak, including paid sick leave, insurance coverage of coronavirus testing, nutrition assistance, and unemployment benefits.
-
Private Health Coverage of COVID-19: Key Facts and Issues
Issue BriefNew federal legislation will require most private health plans to cover testing for the coronavirus with no cost sharing. Some states have adopted similar requirements for insurers they regulate, and many private insurance companies will voluntarily expand coverage for testing. However, some private coverage will not be subject to these requirements. To date, fewer changes have been adopted or considered with respect to treatment for complications from the disease. This brief reviews current coverage standards for private health plans and how these may change in response to the COVID-19 pandemic.
-
Novel Coronavirus “COVID-19”: Special Considerations for Pregnant Women
Issue BriefWith over 6 million pregnancies per year in the U.S., pregnant and breastfeeding women constitute a significant portion of the population that could be impacted by COVID-19. This brief summarizes what is known thus far about pregnancy and COVID-19.
-
The U.S. Response to Coronavirus: Summary of the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Issue BriefThe Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020, which was passed with near unanimous support in both the House and Senate, was signed into law by the President on March 6, 2020. The bill provides $8.3 billion in emergency funding for federal agencies to respond to the coronavirus outbreak. This summary provides details on funding specified in the bill.